Ikena Oncology
Patents, Design & Utilities
Last updated:
List of all Ikena Oncology patents 11 in total
Status | Patent |
---|---|
Application | Utility: TEAD INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Indole AHR inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: INDOLE AHR INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Tead inhibitors and uses thereof Filling date: 7 Sep 2025 Issue date: 15 Mar 2022 |
Application | Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: POLYMORPHIC COMPOUNDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: AHR INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: TEAD INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: INDOLE AHR INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 22 Oct 2020 |
Showing 1 to 11 of 11 patents.